Mark Bierschbach

Mark Bierschbach ( MARK BIERSCHBACH ) is A Dentist Physician in Milbank, SD. The NPI Number for Mark Bierschbach is 1083606180.

The current location address for Mark Bierschbach is 1203 E 4TH AVE Milbank, SD 57252 and the contact number is 6054325032 and fax number is 6054324844. The mailing address for Mark Bierschbach is PO BOX 592 Milbank, SD 57252- 6054325032 (mailing address contact number - 6054325032).

A dentist is a person qualified by a doctorate in dental surgery (D.D.S.) or dental medicine (D.M.D.), licensed by the state to practice dentistry, and practicing within the scope of that license. There is no difference between the two degrees: dentists who have a DMD or DDS have the same education. Universities have the prerogative to determine what degree is awarded. Both degrees use the same curriculum requirements set by the American Dental Association's Commission on Dental Accreditation. Generally, three or more years of undergraduate education plus four years of dental school is required to graduate and become a general dentist. State licensing boards accept either degree as equivalent, and both degrees allow licensed individuals to practice the same scope of general dentistry. Additional post-graduate training is required to become a dental specialist.

What is the NPI Number for Mark Bierschbach ?

Answer: The NPI Number for Mark Bierschbach is 1083606180

Where is Mark Bierschbach located?

Answer: Mark Bierschbach is located at 1203 E 4TH AVE Milbank, SD 57252.

What is the specialty for Mark Bierschbach ?

Answer: The Specialty of Mark Bierschbach is A Dentist Physician.

Are there any online reviews for Mark Bierschbach ?

Answer: Not yet!

Are there any other health care providers in Milbank, SD?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dentist
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	45
Number of Standardized 30-Day Fills	57
Aggregate Cost Paid for All Claims	670.81
Number of Day's Supply for All Claims	936
Number of Medicare Beneficiaries	23
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	43
Aggregate Cost Paid for Generic Drugs	648.63
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst	*
Number of Claims for Beneficiaries Covered by MAPD Plans
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst	#
Number of Claims for Beneficiaries Covered by Standalone PDP Plans
Aggregate Cost Paid for Claims Filled by
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	0
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	0
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	45
by Low-Income Subsidy	670.81
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	30
Aggregate Cost Paid for Antibiotic Drugs	188.47
Antibiotic Claims	19
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	72.739130435
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	11
Number of Male Beneficiaries	12
Number of Non-Hispanic White	23
Number of Black or African American	0
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not	0
Only Entitlement	23
Average Hierarchical Condition Category	0.861173913